Information
-
Trademark
-
97628473
-
International Classifications
-
Filing Date
October 12, 2022
3 years ago
-
Transaction Date
April 30, 2025
7 months ago
-
Status Date
April 29, 2025
7 months ago
-
Published for Opposition Date
March 04, 2025
9 months ago
-
Location Date
April 29, 2025
7 months ago
-
Status Code
688
-
Current Location
INTENT TO USE SECTION
Employee Name
MURRAY, TY
-
Attorney Docket Number
506634-244
Attorney Name
Daan G. Erikson
Law Office Assigned Location Code
M40
-
Owners
Mark Drawing Code
4
Mark Identification
VERIPURE
Case File Statements
- GS0051: Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of tumors; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of solid tumors, namely, melanoma, breast cancer, basal cell carcinoma, prostate cancer, and small cell and non-small cell lung cancer, squamous cell carcinoma and primary and metastatic liver cancers; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of pediatric solid tumors, namely, Ewing sarcoma, neuroblastoma, osteosarcoma, neuroepithelioma, and rhabdomyosarcoma; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of leukemia; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of leukemia, namely, acute B-cell lymphoblastic leukemia, T-cell lymphoblastic leukemia, acute myeloid leukemia; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of psoriasis; Preparations for pharmaceutical skin care; Diagnostic preparations for medical use, namely, for use in virology, microbiology, ophthalmology; Diagnostic mediums for use in virology, microbiology, ophthalmology; Pharmaceutical preparations and substances for use as vaccine adjuvants, immune system stimulators or suppressors, and immune system modulators
- GS0011: Diagnostic reagents for in virology, microbiology and ophthalmology
Case File Event Statements
-
10/17/2022 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
10/15/2022 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
7/27/2023 - 2 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
7/27/2023 - 2 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
7/27/2023 - 2 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
7/27/2023 - 2 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
2/10/2025 - 9 months ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
8/17/2023 - 2 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
8/17/2023 - 2 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
8/17/2023 - 2 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/17/2023 - 2 years ago
10 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
8/17/2023 - 2 years ago
11 - CORRESPONDENCE E-MAILED
Type: GRML
-
2/14/2024 - a year ago
12 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
8/12/2024 - a year ago
13 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
2/26/2025 - 9 months ago
15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
3/4/2025 - 9 months ago
16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
3/4/2025 - 9 months ago
17 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
4/29/2025 - 7 months ago
18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM